MIRM in the 13F filings
Mirum Pharmaceuticals Inc · CUSIP 604749101
- Quarter end
- 31 Dec 2024
- the date the book describes
- Filed
- 14 Feb 2025
- latest of these filings; the earliest 14 Feb 2025
- Managers listing it
- 3
- at least, of 95 tracked, among listed positions
- Comparable managers
- 94
- filed both Q3 2024 and Q4 2024; 3 listed it in both
- Shares listed
- 5,099,759
- combined, among listed positions
- Reported value
- $211m
- combined, at the quarter end
Among the 94 comparable managers: 3 buyers (opened or added shares) and 0 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +174,758.
Managers listing MIRM in Q4 2024
3 of 3 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| Janus Henderson Group Ltd | 4,581,642 | $189m | 0.10% | Added | +101,358 | 14 Feb 2025 (the filing on sec.gov) |
| Woodline Partners LP | 404,404 | $17m | 0.11% | Added | +73,399 | 14 Feb 2025 (the filing on sec.gov) |
| PDT Partners LLC | 113,713 | $4.7m | 0.42% | Added | +1 | 14 Feb 2025 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- Janus Henderson Group Ltdexisting position · 4,581,642 shares now+101,358
- Woodline Partners LPexisting position · 404,404 shares now+73,399
- PDT Partners LLCexisting position · 113,713 shares now+1
Reductions
No reduction among listed positions.
New positions and exits
New (0)
No new position among listed positions.
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2020 | 1 | $1.7m | n.a. | n.a. |
| Q3 2022 | 1 | $7.5m | n.a. | n.a. |
| Q4 2022 | 1 | $7.0m | n.a. | n.a. |
| Q1 2023 | 2 | $26m | n.a. | n.a. |
| Q2 2023 | 2 | $24m | n.a. | n.a. |
| Q3 2023 | 3 | $87m | n.a. | n.a. |
| Q4 2023 | 2 | $68m | 1 | 1 |
| Q1 2024 | 2 | $75m | 1 | 1 |
| Q2 2024 | 3 | $179m | 2 | 1 |
| Q3 2024 | 3 | $192m | 2 | 1 |
| Q4 2024 | 3 | $211m | 3 | 0 |
| Q1 2025 | 3 | $251m | 3 | 0 |
| Q2 2025 | 4 | $304m | 4 | 0 |
| Q3 2025 | 10 | $609m | 6 | 2 |
| Q4 2025 | 8 | $613m | 14 | 15 |
| Q1 2026 | 11 | $1.1bn | 20 | 11 |
| Q2 2026 | 10 | $1.6bn | 11 | 20 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
MIRM and LLY →MIRM and JNJ →MIRM and VRTX →Choose a stock to compare with MIRM →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own MIRM, latest filings →Back to the 13F Explorer →